Cellular, Molecular Consequences of Peroxisome Proliferator- Activated Receptor-δ Activation in Ovarian Cancer Cells
Open Access
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapyNucleic Acids Research, 2006
- Involvement of PPAR nuclear receptors in tissue injury and wound repairJournal of Clinical Investigation, 2006
- Combinatorial roles of nuclear receptors in inflammation and immunityNature Reviews Immunology, 2005
- Inhibitors of the Arachidonic Acid Pathway and Peroxisome Proliferator–Activated Receptor Ligands Have Superadditive Effects on Lung Cancer Growth InhibitionCancer Research, 2005
- Origins and molecular pathology of ovarian cancerLaboratory Investigation, 2005
- Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonistsThe Lancet Oncology, 2004
- Up-regulation of p21 Gene Expression by Peroxisome Proliferator-Activated Receptor γ in Human Lung Carcinoma CellsClinical Cancer Research, 2004
- Regulation of apoptosis proteins in cancer cells by ubiquitinOncogene, 2004
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998